Mehling Lena-Maria, Wang Xin, Johansen Sys-Stybe, Spottke Annika, Heidbreder Anna, Young Peter, Madea Burkhard, Hess Cornelius
Institute of Forensic Medicine, University Hospital Bonn, Stiftsplatz 12, 53111 Bonn, Germany.
Department of Forensic Medicine, University of Copenhagen, Frederik V's Vej 11, 2100 Copenhagen, Denmark.
Forensic Sci Int. 2017 Sep;278:e8-e13. doi: 10.1016/j.forsciint.2017.07.027. Epub 2017 Jul 31.
Gamma-hydroxybutyric acid (GHB) can be used as a knock-out drug in drug facilitated crime (DFC). Due to its rapid metabolism and resulting narrow detection window, uncovering GHB use in DFC still constitutes a problem. In this experiment we determined the GHB and GHB-β-O-glucuronide (GHB-Gluc) concentrations in hair samples after single and chronic GHB exposures. Hair samples of three narcoleptic patients therapeutically taking sodium oxybate (GHB-sodium-salt) were collected. Patients 1 (P1) and 2 (P2) took the medication for nine and six years, respectively. P1 took daily the pharmaceutical Xyrem in a total dose of 5.78g GHB at bed time (2.89g) and four hours (2.89g) later. P2 took a dose of 3.10g GHB at bed time and an additional dose of 2.68g GHB four hours later. Patient 3 (P3) was newly diagnosed with narcolepsy and started his therapy with oral dose of 6g (divided in three portions of 2g GHB) within 24h. The hair samples were extracted both with and without forerunning washing steps. GHB and GHB-Gluc were determined by a published ultra-high performance liquid chromatography-tandem mass spectrometry method using GHB-d and GHB-Gluc-d as internal standards. GHB and GHB-Gluc concentrations in unwashed hair samples of P1 and P2 were determined in a range of 0.56-1.30ng/mg and <0.48-0.85ng/mg, respectively. In washed hair samples of P1 and P2 the concentrations were in a range of <0.32-0.68ng/mg and <0.48-1.20ng/mg for GHB and GHB-Gluc, respectively. The determined concentrations were within the published endogenous range. The confirmed results showed that the washing procedure before extraction causes a minor decrease of GHB concentrations in hair (difference: <1ng/mg). The investigations showed that a single GHB exposure might not be determined by hair analysis of GHB and GHB-Gluc. The chronical intake of therapeutic sodium oxybate with doses up to 7g per night was also not confirmed by hair analysis maybe due to hair treatments. Therefore, GHB hair analysis should be assessed critically and determined negative results could not exclude GHB exposures.
γ-羟基丁酸(GHB)可在药物辅助犯罪(DFC)中用作麻醉药物。由于其代谢迅速且检测窗口期狭窄,在DFC中发现GHB的使用仍然是一个问题。在本实验中,我们测定了单次和长期暴露于GHB后毛发样本中GHB和GHB-β-O-葡萄糖醛酸苷(GHB-Gluc)的浓度。收集了三名发作性睡病患者治疗性服用羟丁酸钠(GHB钠盐)后的毛发样本。患者1(P1)和患者2(P2)分别服药9年和6年。P1每天在睡前(2.89g)和4小时后(2.89g)服用总量为5.78g GHB的药物Xyrem。P2在睡前服用3.10g GHB剂量,并在4小时后额外服用2.68g GHB剂量。患者3(P3)新诊断为发作性睡病,并在24小时内开始口服剂量为6g(分为三份,每份2g GHB)的治疗。毛发样本在有和没有预洗步骤的情况下均进行了提取。使用GHB-d和GHB-Gluc-d作为内标,通过已发表的超高效液相色谱-串联质谱法测定GHB和GHB-Gluc。P1和P2未清洗毛发样本中GHB和GHB-Gluc的浓度分别在0.56 - 1.30ng/mg和<0.48 - 0.85ng/mg范围内。在P1和P2清洗后的毛发样本中,GHB和GHB-Gluc的浓度分别在<0.32 - 0.68ng/mg和<0.48 - 1.20ng/mg范围内。所测定的浓度在已发表的内源性范围内。确认结果表明,提取前的清洗程序会使毛发中GHB浓度略有下降(差异:<1ng/mg)。研究表明,单次GHB暴露可能无法通过对GHB和GHB-Gluc的毛发分析来确定。每晚服用高达7g治疗剂量的羟丁酸钠的长期摄入量也未通过毛发分析得到证实,这可能是由于毛发处理的原因。因此,应谨慎评估GHB毛发分析,确定为阴性的结果不能排除GHB暴露。